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OBJECTIVES The objective of this study was to compare electroanatomic mapping for the assessment of
myocardial viability with nuclear metabolic imaging using positron emission computed
tomography (PET) and with data on functional recovery after successful myocardial
revascularization.
BACKGROUND Animal experiments and first clinical studies suggested that electroanatomic endocardial
mapping identifies the presence and absence of myocardial viability.
METHODS Forty-six patients with prior ($2 weeks) myocardial infarction underwent fluorine-18
fluorodeoxyglucose (FDG) PET and Tc-99m sestamibi single-photon emission computed
tomography (SPECT) before mapping and percutaneous coronary revascularization. The left
ventricular endocardium was mapped and divided into 12 regions, which were assigned to
corresponding nuclear regions. Functional recovery using the centerline method was assessed
in 25 patients with a follow-up angiography.
RESULTS Regional unipolar electrogram amplitude was 11.0 mV 6 3.6 mV in regions with normal
perfusion, 9.0 mV 6 2.8 mV in regions with reduced perfusion and preserved FDG-uptake
and 6.5 mV 6 2.6 mV in scar regions (p , 0.001 for all comparisons). At a threshold
amplitude of 7.5 mV, the sensitivity and specificity for detecting viable (by PET/SPECT)
myocardium were 77% and 75%, respectively. In infarct areas with electrogram amplitudes
.7.5 mV, improvement of regional wall motion (RWM) from 22.4 SD/chord 6 1.0
SD/chord to 21.5 SD/chord 6 1.1 SD/chord (p , 0.01) was observed, whereas, in infarct
areas with amplitudes ,7.5 mV, RWM remained unchanged at follow-up (22.3 SD/
chord 6 0.7 SD/chord to 22.4 SD/chord 6 0.7 SD/chord).
CONCLUSIONS These data suggest that the regional unipolar electrogram amplitude is a marker for
myocardial viability and that electroanatomic mapping can be used for viability assessment in
the catheterization laboratory. (J Am Coll Cardiol 2001;38:91–8) © 2001 by the American
College of Cardiology
Recently, a catheter-based nonfluoroscopic endocardial
electroanatomic mapping system has been developed and
validated in animal experiments (1,2). Since myocardial
ischemia and infarction result in significantly reduced elec-
trical parameters of the affected myocardium (3,4), the local
endocardial electrogram has been proposed as an indicator
of myocardial viability. The system’s ability to provide
information about regional electrical and mechanical prop-
erties of the left ventricle (LV) has previously been evaluated
in animal models and in human studies (2,5–10).
The purpose of this study was to compare the assessment
of myocardial viability in patients who have had a prior
myocardial infarction (MI), and corresponding regional wall
motion (RWM) abnormalities, by using the endocardial
mapping system with the results obtained by using meta-
bolic positron emission computed tomography (PET) im-
aging and with data on functional recovery after successful
revascularization.
METHODS
Patients. Patients with previous MI (.2 weeks) and
RWM abnormalities at rest and with a clinical indication
for a percutaneous revascularization were included in this
study. After diagnostic angiography and before balloon
angioplasty or percutaneous recanalization, all patients un-
derwent PET and single photon emission computed to-
mography (SPECT) imaging. In patients without evidence
for maintained viability from the results of both PET/
SPECT imaging and electroanatomic mapping, a percuta-
neous transluminal coronary angioplasty (PTCA) was per-
formed when the procedure was thought to impose minimal
risk on the patient and the target lesion was located in a
large and dominant vessel. Echocardiography was per-
formed one day before the intervention to exclude intraven-
tricular thrombus. An additional biplane LV angiography
was performed in all patients immediately before mapping
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to eliminate discrepancies induced by spontaneous changes
of global or regional function between the diagnostic cath-
eterization and the time of endocardial mapping. The
coronary intervention was performed immediately after
obtaining the electroanatomic map.
The institutional ethical committee approved the study
protocol, and patients gave informed consent.
Electroanatomic mapping and data postprocessing. The
intraventricular mapping and navigation system (NOGA,
Biosense-Webster, Diamond Bar, California) has been
described in detail previously (2,5).
Unipolar signals filtered at 0.5 Hz to 400 Hz were
recorded in this study, and an interpolation threshold of
40 mm was used. Maps of unipolar electrogram amplitudes
were obtained by displaying the peak-to-peak amplitude of
the unipolar electrogram on a graded color scale.
Additionally, mechanical maps were reconstructed using
the function of linear local shortening. In principle, this
parameter is calculated for each point as the mean value of
the systolic linear movement of every surrounding acquired
point in the direction of the point (normalized to the
distance during diastole) (5).
In this study, the position of the reconstructed apex was
compared to the apex of the biplane LV angiogram obtained
before mapping and reset manually in case of discordant
findings.
Points were deleted from the map if one of the following
criteria was met:
1) Loop stability (mean distance between the location of
the catheter at two consecutive beats at corresponding
time points in the cardiac cycle) was .6 mm;
2) Location stability (distance of the end-diastolic catheter
tip location between two consecutive heart beats) was
.6 mm;
3) Deviation from the mean cycle length was .15%;
4) One of two consecutive beats was a premature beat;
5) Two consecutive endocardial electrograms were different
in morphology; or
6) Two consecutive QRS complexes of the surface electro-
cardiogram were different in morphology.
Additionally, inner points were deleted from the map using
a computer algorithm. It compares the relative depth of a
point within the reconstruction with its neighboring points
localized within a cone formed around a line connecting the
investigated point and the center of the reconstruction (tip
of the cone). Points with a relative depth .10% using a
cone angle of 25° were deleted from the map.
A polar projection of the LV along an axis from the
center of mass of the reconstructed ventricle to the apex was
generated. The reconstructed ventricle was divided into
three parts (apex, midventricle and base, consisting of 20%,
40% and 40% of the long-axis length, respectively), and the
longitudinal location of each endocardial site was deter-
mined on the basis of its projection on this axis. The three
parts were each further divided into four regions: septal
(120° of the circumference), anterior (80°), lateral (80°) and
inferior (80°) (Fig. 1). Thus, in this polar view, the ventricle
was divided into 12 regions. Mean values for the peak-to-
peak amplitudes of the unipolar electrograms were calcu-
lated for each region.
Technetium-99m sestamibi SPECT imaging. Since an
on-site cyclotron is not available at our institution, we use a
combination of perfusion imaging with Tc99m sestamibi
SPECT and metabolic imaging with F-18 fluorodeoxyglu-
cose (FDG) for myocardial viability assessment (11,12).
Nuclear studies were performed after diagnostic catheter-
ization and before the mapping and PTCA. Patients were
studied at rest 2 h after injection of 10 mCi Tc-99m
sestamibi with a light meal after tracer application. Data
were acquired using a double head gamma camera (Solus,
ADAC Lab., Milpitas, California), axial full field of view
55.5 cm and matrix size 128 3 128. Reconstruction
including attenuation and scatter correction was performed
as described before (13).
Fluorine-18 FDG PET imaging. After transmission im-
aging and glucose loading with 50 g dextrose orally, 6 to 8
mCi FDG were injected. Static imaging for 30 to 40 min
was initiated 30 to 45 min after tracer injection using a PET
scanner ECAT EXACT (CTI, Knoxville, Tennessee),
Abbreviations and Acronyms
AUC 5 area under the curve
CI 5 confidence interval
FDG 5 F-18 fluorodeoxyglucose
LAD 5 left anterior descending artery
LCX 5 left circumflex artery
LV 5 left ventricle or left ventricular
MI 5 myocardial infarction
PET 5 positron emission computed tomography
PTCA 5 percutaneous transluminal coronary
angioplasty
RCA 5 right coronary artery
ROC 5 receiver operator curve
RWM 5 regional wall motion
SPECT 5 single photon emission computed tomography
Figure 1. Polar plot and segmentation of the LV for positron emission
computed tomography (PET)/single photon emission computed tomog-
raphy (SPECT) and mapping analysis. The segmentation methods for
both modalities are described in detail in the Methods section. Positron
emission computed tomography/SPECT regions (n 5 25) were grouped
(see numbers), and mean values were calculated and assigned (same
numbers for corresponding regions) to the mapping regions (n 5 12).
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matrix size 128 3 128, axial field of view 49.7 cm and axial
width 15 cm in three bed positions. Reconstruction was
performed by filtered back projection (Hanning, cutoff
frequency 0.4 and zoom 1.12). Positron emission tomogra-
phy and SPECT imaging were performed on the same day
in all patients.
PET and SPECT analysis. Left ventricular long axis was
defined interactively, and quantitative analysis was per-
formed in the two data sets using a vector based automatic
segmentation program (modified ECAT software, CTI)
(14). The values of 450 vector profiles for SPECT and PET
studies were assigned to 33 regions of a polar map. Sesta-
mibi and FDG uptake was expressed as percentage of the
region with the maximal sestamibi uptake. The polar map
divides the ventricle into six slices, each covering approxi-
mately 17% of the long-axis length. Because high variations
are usually found in the most basal regions, the outer slice
was not considered for analysis. As shown in Figure 1, the
four remaining outer slices were further subdivided into
anterior, septal, inferior and lateral regions (each 90° of the
circumference); the apical slice was not further subdivided.
In order to compare nuclear and mapping data on a
regional basis, 25 regions of the PET and SPECT datasets
were assigned to the 12 regions of the electroanatomic
regional polar map. Since both modalities use different
segmentation methods, nuclear regions had to be arranged
as shown in Figure 1, and the mean uptake value was
calculated.
The applied definitions for myocardial viability based on
the literature (11,15–18) are shown in Table 1.
Analysis of RWM. Regional wall motion was analyzed
using a modified centerline method (QUANTCOR.LVA,
Siemens, Germany) from digitized angiograms (19). Vessel
territories were assigned to contiguous chords as previously
described (19). Regional wall motion was assessed in the
territory of the target vessel and in the territory of a patent
and noninfarct-related vessel in each patient. Left ventric-
ular ejection fraction was determined by the area-length
method from the 30° right anterior oblique angiogram.
Statistical analysis. Data are presented as mean 6 SD.
Data were analyzed on a patient basis. In a first approach, all
regions were included in the analysis, and values were
averaged for a given region type for a given patient, thereby
obtaining a single value for that region type for that patient.
In a second approach, the value of the region representing
the center of the infarct area was used in every patient.
Differences in continuous variables were measured using
repeated measures analysis of variance with Bonferroni post
hoc analysis and Student t test for paired and unpaired
samples. Receiver operating curve (ROC) analysis was
performed with MedCalc 4.16a software (Mariakerke, Bel-
gium). Spearman correlation coefficients were calculated.
RESULTS
Patients. Forty-six patients (32 men, 59 6 10 years) were
included in the study. Twenty-six patients had an anterior
MI; 14 patients had an inferior MI. Six patients had no
clinical history of MI but had severe RWM abnormalities in
the territory of the target vessel (two inferior, four anterior).
The median time interval from infarction to revasculariza-
tion was 88 days and from PET/SPECT imaging to
mapping and revascularization was 24 days. Clinically, there
was no evidence for cardiac events between PET/SPECT
imaging and mapping. Angiographic ejection fraction was
49 6 15%. Twenty-four patients had single-vessel disease;
16 patients had two-vessel disease; and 6 patients had
three-vessel disease. Target lesions were located in the LAD
in 27 patients, in the RCA in 12 patients, in the LCX in 4
patients and in bypass grafts in 3 patients (one LAD, two
RCA). Twenty-two patients had a complete occlusion of
the target vessel.
PET/SPECT imaging and electroanatomic mapping.
The nuclear polar maps of the 46 patients were divided into
12 regions matching the mapping polar maps. Due to
technical difficulties, no mapping points were acquired in 17
regions, and these regions were subsequently not considered
for quantitative analysis. Results of PET/SPECT analysis
are shown in Table 1.
The average number of points acquired per patient after
postprocessing was 76 6 18, with 6 6 2 points per region.
The time to obtain a complete map was 52 6 21 min. The
minimal recorded value for the regional unipolar amplitude
was 1.3 mV, and the highest value was 29.8 mV, with a
mean value of 10.4 mV 6 4.7 mV. No complications
occurred during the mapping procedures.
Table 1. Unipolar Electrogram Amplitude and Linear Local Shortening in Regions Defined by Nuclear Imaging
PET/SPECT Imaging (definitions) n
Unipolar
Electrogram
Amplitude
(mV)
Local
Shortening
(%)
Unipolar Electrogram
Amplitude (mV)/Patients
With All Types of Regions
(n 5 27)
Local Shortening (%)/
Patients With All Types
of Regions
(n 5 27)
Normal Perfusion (sestamibi uptake . 70%) 46 11.8 6 3.6 8.9 6 4.1 11.0 6 3.6* 7.3 6 3.8*†
(9.1–14.6) (4.7–13.4) (8.2–12.8) (4.1–10.3)
Reduced perfusion, preserved metabolism (sestamibi
uptake , 70% & FDG uptake $50%)
45 9.4 6 3.0 5.7 6 4.0 9.0 6 2.8* 4.6 6 3.5†
(6.7–11.4) (2.1–8.5) (6.8–11.1) (2.3–7.1)
Scar (sestamibi uptake & FDG uptake ,50%) 28 6.5 6 2.5 1.7 6 4.7 6.5 6 2.6* 1.5 6 4.7*†
(4.6–7.2) (20.6–6.7) (4.6–7.6) (20.7–5.0)
*p , 0.001; †p , 0.01. Numbers in brackets represent 25% to 75% percentiles.
FDG 5 F-18 fluorodeoxyglucose; PET 5 positron emission computed tomography; SPECT 5 single photon emission computed tomography.
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Comparison of electroanatomic mapping and PET/
SPECT results. The regional unipolar amplitude was sig-
nificantly different between normally perfused regions, re-
gions with reduced perfusion but preserved metabolism and
scar regions (Table 1).
The percentage of regions with an FDG uptake .70%
ranged from 12% in regions with severe Tc-99m defects and
up to 34% in regions with moderate Tc-99m defects (Fig.
2). Similar results were found for the unipolar electrogram
amplitude; the percentage of regions with an amplitude .9
mV ranged from 19% in regions with severe Tc-99m defects
up to 39% in regions with moderate Tc-99m defects (Fig.
2). In regions with severely reduced sestamibi uptake
(,50%) but preserved FDG uptake ($50%), the unipolar
electrogram amplitude was 8.1 mV 6 3.6 mV, compared
with 6.6 mV 6 2.7 mV in regions with severely reduced
sestamibi uptake and concordantly reduced FGD uptake
(both ,50%).
To assess the ability of electroanatomic mapping of
regional unipolar amplitudes for discrimination of viable
and scar regions, a ROC analysis comparing regions with
evidence of maintained viability (normal regions and regions
with reduced perfusion but preserved metabolism) with scar
regions was performed on a patient basis (original regions
n 5 536). The area under the curve (AUC) was 0.84 (95%
confidence interval (CI): 0.76 to 0.90) (Fig. 3). After
exclusion of the most basal regions with mean regional
amplitudes ,6 mV, the analysis of the remaining regions
(n 5 500) yielded an AUC of 0.88 (95% CI: 0.81 to 0.93).
Using a threshold electrogram amplitude of 7.5 mV, the
sensitivity and specificity for detecting viable myocardium
were 77% and 75%, respectively. At 6 mV the sensitivity was
96% (specificity 57%), and at 9 mV the specificity was 82%
(sensitivity 65%). After exclusion of the most basal regions
with mean regional amplitudes ,6 mV, sensitivity and
specificity (threshold 7.5 mV) were 85% and 81%, respec-
tively.
For the septal regions (regions 1 to 3 in Fig. 1), the ROC
analysis revealed an AUC of 0.83, for the anterior regions
(regions 4 to 6), 0.76; for the lateral regions (regions 7 to 9),
0.94 and for the inferior regions (regions 9 to 12), 0.90.
Images of a patient with an apical scar and reduced
perfusion but preserved FDG uptake in the surrounding
anterior myocardium are illustrated in Figure 4. The corre-
sponding unipolar amplitude map displays an area of low
amplitude only in the apical region, whereas the rest of the
anterior wall had higher unipolar amplitudes indicating
preserved viability.
Linear local shortening was significantly different among
normally perfused myocardium, regions with reduced per-
fusion and scar regions (Table 1). The ROC analysis for
identification of scar revealed an AUC of 0.81 (95% CI:
0.73 to 0.88). Combining the information from linear local
shortening and the unipolar electrogram amplitude (AUC
of 0.86 [95% CI: 0.79 to 0.92]) did not increase the
diagnostic accuracy compared with the analysis of the
unipolar electrogram amplitude alone. Linear local shorten-
Figure 2. Percentage of regions with normal and absent metabolism
(upper panel) and electrical activity (lower panel), respectively, in relation
to sestamibi uptake. In the upper panel, normal metabolism is defined by
an F-18 fluorodeoxyglucose (FDG) uptake $70% and absent metabolism
by an uptake ,50%. In the lower panel, normal electrical activity is defined
by an electrogram amplitude .9 mV and absent activity as ,6 mV.
Figure 3. Receiver operator curve (ROC) analysis for detection of viable
regions (normal perfusion, reduced perfusion but preserved metabolism)
versus scar regions by the unipolar electrogram amplitude on a patient
basis. The solid line represents the ROC curve for all regions (original
regions n 5 536); the dashed line represents the ROC curve for all regions
minus the basal regions with regional unipolar amplitudes ,6 mV (n 5
500).
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ing correlated with the regional unipolar electrogram am-
plitude (r 5 0.57, p , 0.001).
Comparison of electroanatomic mapping with PET/
SPECT and RWM in infarct area. For comparison of
electroanatomic mapping with PET/SPECT and RWM,
we performed an analysis per infarct area using the value of
the region representing the center of the infarct area.
In patients with nonviable myocardium by nuclear imag-
ing, the unipolar electrogram amplitude was 6.1 mV 6
2.0 mV in the infarct area, whereas, in patients with viable
myocardium, the unipolar electrogram amplitude was
11.4 mV 6 3.6 mV in the infarct area (p , 0.001). The
AUC by ROC analysis was 0.92 (95% CI: 0.80 to 0.98). At
a threshold amplitude of 7.5 mV, the sensitivity was 90%
and the specificity was 81%. The corresponding values for
local shortening were 2.0 6 4.5% for nonviable and 7.2 6
5.4% (p , 0.01) for viable myocardium with an AUC of
0.77 (95% CI: 0.63 to 0.88).
Linear local shortening, as a parameter of regional me-
chanical function derived from electromechanical mapping,
was 4.3 6 5.5% in infarct areas versus 11.0 6 4.8% in
remote control areas (p , 0.001). Regional unipolar ampli-
tude in these areas was 8.4 mV 6 3.9 mV and 13.3 mV 6
4.0 mV (p , 0.001), respectively. Linear local shortening
correlated with the regional unipolar electrogram amplitude
(r 5 0.56, p , 0.001).
Unipolar electrogram amplitude and linear local shorten-
ing did not differ between anterior infarcts and inferior
infarcts (7.6 mV 6 2.8 mV vs. 8.6 mV 6 4.8 mV, p 5 NS
and 3.2 6 4.7% vs. 5.5 6 5.4%, p 5 NS, respectively).
There was a significant correlation between linear local
shortening and RWM with r 5 0.61 (p , 0.001) but no
correlation between regional electrogram amplitude and
RWM (r 5 2 0.13, p 5 NS).
Results of electroanatomic mapping and PET/SPECT
imaging versus recovery of global and regional LV func-
tion. Follow-up angiography was performed after six
months in 28 patients demonstrating patent revascularized
vessels with a diameter stenosis ,50% in 25 patients. Seven
patients did not undergo follow-up angiography, because of
either unsuccessful recanalization (two patients), death (two
patients), reinfarction (two patients) or ischemic disabling
stroke (one patient) during follow-up. Eleven patients were
lost to follow-up (three patients) or did not consent to
follow-up angiography (eight patients).
Left ventricular ejection fraction improved significantly
from 52 6 16% to 62 6 13% (p 5 0.01) in 13 patients in
which mapping of infarct areas had shown regional
unipolar electrogram amplitudes .7.5 mV, whereas ejec-
tion fraction did not change (50 6 12% to 50 6 11%) in
12 patients with regional unipolar amplitudes ,7.5 mV
in the target area.
Similarly, RWM improved from 22.4 SD/chord 6 1.0
SD/chord to 21.5 SD/chord 6 1.1 SD/chord (p , 0.01) in
infarct areas with electrogram amplitudes .7.5 mV,
whereas RWM remained unchanged (22.3 SD/chord 6
Figure 4. (A) Right anterior oblique view of the left ventricular angiogram at end-diastole (ed) and end-systole (es) of a patient with severe hypokinesia
of the anterior wall after anterior myocardial infarction. (B) Long- and short-axis positron emission computed tomography (PET) and single photon
emission computed tomography (SPECT) images and corresponding polar maps showing an apical scar and reduced perfusion but preserved F-18
fluorodeoxyglucose (FDG) uptake in the surrounding anterior wall. (C) Unipolar amplitude map of the LV obtained by endocardial mapping (left: right
anterior oblique view [RAO]; right: anteroposterior [AP] view). Color coding ranges from ,6 mV (red) to .25 mV (purple). The apex is displayed with
low amplitude, whereas the adjacent anterior wall has higher amplitudes. (D) Regional polar view of the unipolar amplitude map of the LV, divided into
12 regions. MIBI 5 Tc 99m sestamibi.
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0.7 SD/chord before revascularization vs. 22.4 SD/chord 6
0.7 SD/chord at follow-up, p 5 NS) in infarct areas with
amplitudes ,7.5 mV. Regional wall motion in control areas
did not change significantly (0.8 6 1.5 SD/chord to 0.6 6 1.7
and 0.1 6 1.4 to 0.0 6 1.0 SD/chord, respectively) (Fig. 5).
The unipolar electrogram amplitude was significantly
higher in functionally recovering areas than it was in areas
without improvement after revascularization (10.2 mV 6
2.4 mV vs. 6.6 mV 6 2.2 mV, p , 0.01). Endocardial
mapping at a threshold of 7.5 mV had a sensitivity of 91%
and a specificity of 71%, whereas PET/SPECT imaging
had a sensitivity of 82% and a specificity of 86% for recovery
of RWM (10.5 SD/chord).
DISCUSSION
Assessment of myocardial viability. The purpose of this
study was to compare the assessment of myocardial viability
by endocardial catheter-based electroanatomic mapping
with metabolic imaging using FDG-PET and, furthermore,
with data on functional recovery after successful revascular-
ization. The results indicate that myocardial regions iden-
tified as scar regions by PET/SPECT imaging have signif-
icantly lower mean regional unipolar amplitudes than
regions identified as viable. Moreover, unipolar electrogram
amplitudes correlated with recovery of regional and global
ventricular function after successful revascularization.
Unipolar electrogram amplitudes were significantly dif-
ferent among normal regions, regions with reduced perfu-
sion but preserved metabolism and scar regions (Table 1).
The ROC analysis revealed an AUC of 0.84, a value that is
commonly considered as sufficient for a diagnostic proce-
dure (Fig. 3). Sensitivity and specificity were in the range
reported for other diagnostic modalities of viability assess-
ment.
As described previously (11), FDG-PET could demon-
strate preserved metabolism in some of those regions with
moderate-to-severe perfusion defects. Similarly, electroana-
tomic mapping identified a considerable number of regions
with perfusion defects as “electrically viable” (Fig. 2).
Preserved unipolar electrogram amplitudes, despite severely
reduced myocardial perfusion, have also been demonstrated
in a pig model using contrast echocardiography and elec-
tromechanical mapping five weeks after placement of an
ameroid constrictor around the circumflex artery (8).
Regional electrical function correlated closely with recov-
ery of RWM after successful revascularization (Fig. 5).
Furthermore, electrogram amplitudes were significantly
higher in recovered regions than they were in regions
without functional improvement.
These data suggest strongly that the electrogram ampli-
tude can be used as a marker of myocardial viability. The
presented data confirm and extend, by serial functional
assessment, the findings of Kornowski et al. (20) who used
thallium-201 SPECT as the reference method for viability
assessment.
Linear local shortening as a mapping parameter of me-
chanical function correlated with angiographically assessed
RWM. Although linear local shortening was significantly
smaller in scar regions than in regions with reduced perfu-
sion but preserved metabolism, the discrimination was less
efficient by ROC analysis, and a combination of both
parameters did not increase the accuracy for discrimination
between viable and nonviable myocardium.
Study limitations. In this study, electromechanical maps
were compared with PET/SPECT and RWM data. The
segmentation of the LV is not identical for the three
methods. Misalignment of the corresponding regions may
lead to discordant findings and a certain degree of error. It
is possible that the results, in fact, underestimate the
diagnostic accuracy of electroanatomic mapping.
Positron emission tomography/SPECT imaging were
not performed at the same time as endocardial mapping.
This may be a source of error, but we consider perfusion and
metabolism in these patients with chronic MI stable enough
to make changes over three to four weeks unlikely. Addi-
tionally, since PET/SPECT imaging was always performed
before mapping, the error should be systematic and similar
for all patients.
Analysis of other electrophysiologic parameters that could
be obtained during endocardial mapping may improve the
diagnostic performance of the mapping system for viability
assessment. These include fractionation of electrograms
(21), amplitude to duration ratio and electromechanical
delay. Novel signal processing methods may be able to
discriminate better between nonviable and viable myocar-
dium (22).
Figure 5. Regional wall motion in the infarct area and control area before
and six months after successful percutaneous transluminal coronary angio-
plasty in patients with regional unipolar electrogram amplitudes in the
infarct area .7.5 mV (n 5 13) and in patients with regional unipolar
electrogram amplitudes in the infarct area ,7.5 mV (n 5 12). SD 5
standard deviation.
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Electromechanical mapping of the basal parts of the LV
includes sites on the valve apparatus with low endocardial
amplitudes due to its fibrous nature. Inclusion of these
points lowers the mean regional amplitude and may produce
false negative results for the regional myocardial viability of
the most basal parts of the LV. In the presented analysis, the
diagnostic accuracy improved after exclusion of the most
basal regions, with regional amplitudes below 6 mV.
It should be emphasized that the accuracy of the method
for assessing viability is likely to be influenced by the point
density and by the training of the interventional cardiolo-
gist. With regard to point density, sampling more points per
entire map and more points per region might further
increase the accuracy of the method. However, this would
be associated with a prolonged mapping time. Mapping of
one region representing the infarct area also allowed an
accurate discrimination of viable and nonviable myocar-
dium, as our analysis showed. With regard to training, we
believe that a training period in 5 to 10 patients is sufficient
for an experienced interventional cardiologist or electro-
physiologist to perform mapping procedures of good diag-
nostic quality.
Finally, these data represent the early experience with the
mapping system and are derived from a relatively small
number of patients. Certainly, studies in larger patient
populations are needed to confirm our findings.
Clinical implications. Endocardial electroanatomic map-
ping can be used in patients with prior MI and RWM
abnormalities to assess myocardial viability in the catheter-
ization laboratory in combination with diagnostic coronary
angiography. It should provide immediate information
about the viability status of the infarcted myocardium and
guide the interventional cardiologist in the decision to
perform an ad hoc revascularization or surgical intervention
without further viability assessment.
Given the existing financial restraints within most health
care systems, the cost of the different methods for myocar-
dial viability assessment must be considered. Currently,
the costs for an FDG PET/Tc99m sestamibi SPECT at
our institution are $1,100 and, for a thallium-201
SPECT, $300.00. The costs for a mapping procedure
(reference and mapping catheter) are currently $2,300.
This difference may be counterbalanced by the advantage
of an ad hoc PTCA guided by an on-line viability
assessment by mapping. However, for making a viability
assessment by endocardial mapping a more attractive
alternative to conventional nuclear imaging, a reduction
in costs would be appropriate.
Endocardial electroanatomic mapping may also be used
in the setting of catheter-based direct myocardial revascu-
larization (23). Scar areas and viable myocardium can be
identified and visualized with this technique, and subse-
quent revascularization procedures can be targeted to viable
regions, avoiding unnecessary treatment of scar tissue.
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